Background. Campylobacteriosis is inflammation of the gastrointestinal tract as a result of Campylobacter infection. Most campylobacteriosis cases are acute and self-limiting, with Campylobacter excretion ceasing a few weeks after symptoms cease. We identified a patient with fecal specimens positive for Campylobacter jejuni (ST45) intermittently during a 10-year period.
Campylobacter are the prime bacterial cause of human enteritis [1] . Campylobacteriosis is associated with diarrhea, abdominal pain, and fever. Most campylobacteriosis cases are acute and self-limiting, with symptoms ceasing after a week [2] . Patients with campylobacteriosis begin excreting Campylobacter organisms at the onset of symptoms and continue to excrete for 2-3 weeks after symptoms subside [3] . Longer periods of excretion can occur in a number of conditions. In cases of chronic campylobacteriosis, patients are unable to clear Campylobacter organisms and experience continuous episodes of diarrhea and Campylobacter-positive feces [4, 5] . Cases of reinfection with Campylobacter species can arise from subsequent exposure and result in symptomatic or asymptomatic campylobacteriosis [6] . Asymptomatic campylobacteriosis cases have fecal specimens positive for Campylobacter species but do not have symptoms. They are more prevalent in developing countries, owing to increased exposures and, possibly, undernutrition-induced immunosuppression [7] .
The Manawatu sentinel surveillance program (MSSP) at m EpiLab, Massey University, in collaboration with Mid-Central District Health Board, collects Campylobacter isolates from human campylobacteriosis cases and food and environmental sources in the Mid-Central region of New Zealand's North Island. Isolates are genotyped, allowing inferences to be made about the sources of human cases [8] . The MSSP identified an individual from whom 7 fecal specimens obtained over a 10-year period (from 2006 to 2016) tested positive for Campylobacter jejuni ST45 .
The aim of this study was to determine whether the patient was persistently infected or reinfected on multiple occasions. We attempted to identify potential sources of infection, to determine the genetic relatedness of isolates, and to determine the effect of long-term excretion and antimicrobial treatment on isolates from the patient.
Interview
The patient was interviewed to identify potential occupational and domestic sources of Campylobacter organisms and to gain further details of their medical history. The patient stated that they had been receiving multiple medications since the onset of diarrhea. After obtaining consent from the patient, their medical records were obtained and investigated for antibiotic use.
Environmental Sampling
To identify sources of Campylobacter organisms that the patient may have been persistently exposed to, domestic sources, as identified in the interview, were cultured for Campylobacter species at a single time point. Fecal samples were obtained from the patient's pets, soil samples from their vegetable gardens, and water samples from their water supply.
Fecal samples were directly plated onto 2 CAT and 2 mCCDA agar plates (Fort Richard Laboratories, Auckland, New Zealand). One set was incubated microaerobically (in 3% O 2 , 5% H 2 , 10% CO 2 , and 82% N 2 ) at 37°C for 48 hours, and the other was incubated microaerobically (in 5% O 2 , 10% CO 2 , and 85% N 2 ) at 42°C for 48 hours to promote the growth of Campylobacter species that grow at 37°C and 42°C and require hydrogen gas. In addition, approximately 100 µg of each fecal sample was inoculated in 10 mL of Bolton broth (Lab M, Heywood, Bury, United Kingdom) and incubated microaerobically (in 5% O 2 , 10% CO 2 , and 85% N 2 ) at 42°C for 48 hours.
Approximately 1 g of each soil sample was inoculated in 10 mL of Bolton broth and incubated microaerobically (in 5% O 2 , 10% CO 2 , and 85% N 2 ) at 42 0 C for 48 hours. A liter of the water sample was filtered through a 0.45-µm-pore nitrocellulose filter (Merck Millipore, Billerica, MA). The filter was inoculated in 10 mL of Bolton broth and incubated microaerobically (in 5% O 2 , 10% CO 2 , and 85% N 2 ) at 42°C for 48 hours.
From each Bolton broth, a loopful was inoculated onto 2 mCCDA and 2 CAT agar plates. One set was incubated microaerobically (in 3% O 2 , 5% H 2 , 10% CO 2 , and 82% N 2 ) at 37°C for 48 hours, and the other was incubated microaerobically (in 5% O 2 , 10% CO 2 , and 85% N 2 ) at 42°C for 48 hours. All cultured oxidase-positive, gram-negative colonies underwent species typing by use of C. jejuni polymerase chain reaction (PCR) analysis.
PCR Analysis
A loopful of Campylobacter species grown for 24 hours was inoculated into an Eppendorf tube containing 1 mL of 2% Chelex (Bio-Rad, Hercules, CA) and incubated at 100°C for 10 minutes. After incubation, each tube was centrifuged for 3 minutes at 12 000 × g. Two microliters of supernatant was removed from each tube and used for PCR analysis. C. jejuni was identified by a PCR method that tests for the presence of hipO [9] .
Strains
Sixteen ST45 isolates were collected from 7 episodes of diarrhea reported to the MSSP from the same patient (during 2006-2016) . C. jejuni NCTC 11168 and NCTC 11531 were obtained from the New Zealand Reference Culture Collection (ESR, Porirua, New Zealand). A nonmotile C. jejuni strain previously isolated from retail poultry through the MSSP was used as a control in motility assays [10] .
Whole-Genome Sequencing
Genomic DNA was extracted from the 16 ST45 isolates, using a QIAamp DNA mini kit (Qiagen, Hilden, Germany) [11] . Genome extracts underwent whole-genome sequencing by New Zealand Genomics at the Massey Genome Service (Massey University, Palmerston North, New Zealand). A library was prepared for each isolate by using an Illumina TruSeq DNA PCR-Free kit (Illumina, Scorsby, Australia) and sequenced by using an lllumina MiSeq (Illumina) as 2 × 250-bp paired-end runs (approximately 120-150 times genome coverage). After sequencing and barcode demultiplexing, PhiX control library reads and adapter sequences were removed using FASTQ-MCF [12] . The raw reads are accessible online via the European Nucleotide Archive (accession no. PRJEB18520; available at: http://www.ebi.ac.uk/ena).
Genomic Assembly
Genomes were assembled de novo. An in-house Perl script trimmed reads at an error probability of 0.01, using solexaQA++ [13] , and generated random subsets of paired reads, from 500 000 to 800 000 paired reads in 100 000 increments, varying the average genome coverage. Each random set was assembled with the de novo assembler Velvet v1.1 [14] , using kmers from 55 to 245 in increments of 10. This resulted in multiple genome assemblies for each isolate. Metrics for each of 4 parameters (longest genome length, fewest number of contigs, largest N 50 value, and longest contig length) were ranked in numerical order, and an overall equally summed ranking score was calculated. The assemblies with the lowest total rank were used. QUAST [15] was used to analyze the ST45 de novo assembly GC contents.
Single-Nucleotide Polymorphism (SNP) Identification
Core SNPs were identified using Snippy v2.6 (available at: https:// github.com/tseemann/snippy) and kSNP v3.0 [16] . The Snippy pipeline uses Burrows-Wheelers Aligner [17] and SAMtools [18] , to align reads from different isolates to a sequence, and FreeBayes [19] , to identify variants among the alignments. kSNP was used to analyze de novo-assembled genomes, along with the reference genome, C. jejuni strain 4031 (NC_022529). An in-house Python script was used to determine the read coverage of all SNPs identified via kSNP. Snippy was used to align reads from each isolate to the reference genome, NC_022529, before identifying SNPs. SNPs were accepted if they had a >10-read depth and a >90% consensus for each isolate. The position of the SNP on the reference genome was used to determine whether both methods identified the SNP or whether they were unique to the method (Supplementary Materials). BRIG [20] was used to compare the de novo-assembled genomes to the reference (Supplementary Materials).
ST45 Comparison
Four ST45 isolates from the MSSP were previously sequenced [21] and uploaded to BIGSdb (available at: https://pubmlst.org/ software/database/bigsdb). The de novo-assembled genomes of these isolates were downloaded from BIGSdb (access available on request) and compared to the de novo-assembled genomes of the 16 ST45 isolates using kSNP3, which found that the isolates shared 5216 core SNPs.
NeighborNet Trees
SplitsTree [22] was used to form a NeighborNet tree of the 16 ST45 isolates collected from the same patient, based on the 196 core SNPs they share, and the 20 ST45 isolates from the patient and other sources, based on the 5216 core SNPs they share.
Phylogenetic Analysis
An in-house Perl script was used to split the 196 core SNPs into groups on the basis of whether they were associated with the first, second, or third codon; contained in overlapping coding regions; or found in intergenic regions. It was also used to determine whether the SNPs were synonymous or nonsynonymous. The partitioned SNPs were exported into BEAUti to create an extended markup language (xml) file for BEAST 1.8.3 [23] . The 5 SNP groups were given separate Hasegawa Kishino Yano substitution models [24] , while their tree and clock models were linked to allow for variation in base substitution among codon positions. The Gaussian Markov random field (GMRF) Bayesian skyride model [25] was used to allow for and estimate changes in the effective population size. An uncorrelated relaxed molecular clock [26] was used to allow for variation in mutation rates among lineages and was calibrated by tip dates. The xml file was run in BEAST for 40 million steps, 3 times with different starting seeds, before LogCombiner was used to combine the runs with a 10% burn-in. Tracer v1.6 [27] was used to visualize the results and the relative change in effective population size.
The mean mutation rate estimated by BEAST was multiplied by the number of core SNPs analyzed (196 bp) and divided by the mean genome size of the isolates analyzed (1 641 217 bp), to give the mutation rate for the ST45 genome. The GMRF Bayesian skyride model was rerun without sequencing data to determine whether the model was picking up a signal or simply sampling from priors.
Protein-Coding Gene Analysis
Proteins and protein differences shared by the 16 ST45 isolates were identified using a previously described method [28] . The functions of the proteins were predicted by comparing their sequences to those in the Clusters of Orthologous Groups of proteins (COGs) database [29] . The number of protein differences in each functional group was divided by the total number of ST45 proteins in each functional group to give the protein difference to quantity ratio.
Antimicrobial Susceptibility
Trek Sensititre plates (Thermo Fisher Scientific, Waltham, MA) were used to measure each isolate's minimum inhibitory concentration (MIC) for erythromycin, ciprofloxacin, tetracycline, gentamycin, nalidixic acid, and streptomycin [30] . Etest strips (Liofilchem, Roseto degli Abruzzi, Italy) were used to measure MICs for ampicillin, sulfamethoxazole, and trimethoprim [31] . The antibiotic susceptibility tests were run in quadruplicate, leaving 40 MICs for the fecal sample collected in 2016 that consisted of 10 Campylobacter isolates.
Motility
Campylobacter motility was measured using a method described by Hanel et al [32] . The Campylobacter isolates from the first 6 episodes had their motility tested 6-8 times, whereas the 10 isolates collected from the final episode and the controls had their motility tested 3-5 times. The first 6 isolates displayed more variation in motility than the other isolates and thus were subjected to more replicates, to reach unbiased conclusions.
Scripts
The in-house scripts used in this study were previously described [28] . They are accessible online from GitHub (available at: https:// github.com/samuelbloomfield/Scripts-for-genomic-analyses).
RESULTS

Patient Background
In 1992, the patient received a diagnosis of common variable immune deficiency (CVID), an immune disorder associated with an increased risk of bacterial infections [33] . Since 1992, they had persistently low serum immunoglobulin A and immunoglobulin G concentrations and had received multiple antibiotic, immunoglobulin replacement, and immunosuppressive therapies. In 2000, they started to experience daily episodes of diarrhea. The severity of the patient's diarrhea varied since its onset, and their medical records showed that certain antibiotic and immunosuppressive therapies and diets decreased the severity of diarrhea but did not eliminate it. 
Genomic ST45 Comparison
Assembled genomes were 1.64-1.66 Mbp in length and had a GC content of 30.45%-30.62%. This is within the normal GC content range for C. jejuni (ie, 28%-33% [34] ).
Genetic Distance
One-hundred and ninety-six core SNPs were identified among the closely related 16 ST45 isolates collected from the patient, with no genetically distinct isolates observed (Figure 1 ). There was an association between the date of collection of the isolates and genetic distance, with a larger genetic distance between isolates collected at distant time points than those collected at closer time points. There was some diversity in the 10 isolates collected from the same episode in 2016, but this was relatively small as compared to the diversity between isolates collected at different time points.
Phylogenetic Analysis
Phylogenetic analysis predicted that the 16 ST45 isolates shared a mean date of common ancestor in June 2002 (95% highest posterior density [HPD] interval, July 1998-January 2006). The 95% HPD interval of the mutation rate was 2.8 × 10 -6 -8.3 × 10 -6 substitutions per site per year. The GMRF Bayesian skyride model was unable to identify any changes in effective population size (Supplementary Figure 4) .
Protein-Coding Gene Analysis
Protein annotation identified 1785 coding-DNA sequences contained among the 16 ST45 isolates, one of which was missing in 1 isolate. Protein analysis also identified 129 nonsynonymous SNPs and 29 indels, yielding 159 protein differences among the 16 ST45 isolates. These 159 protein differences were associated with a large number of COG functional groups, but a disproportionate number were involved in cell motility (COG group N) and signal transduction (COG group T; Figure 2 ).
Antimicrobial Susceptibility
From 2006 to 2016, the patient received multiple courses of antibiotics for various conditions. However, the patient could not recall whether any of these courses alleviated diarrhea.
The ST45 isolates became less susceptible to ampicillin be- (Figure 3) . The medical records of the patient from September 2008 refer to the patient as "being on antibiotics. " However, the specific nature of these antibiotics was not reported. The ampicillin-resistant ST45 isolates collected from February 2009 onward contained a mutation in the promoter region of bla . This gene encodes a β-lactamase gene that degrades β-lactam antibiotics, and the mutation is associated with increased expression of the gene and high-level β-lactam resistance [35] .
All ST45 isolates collected from the patient were resistant to nalidixic acid and ciprofloxacin, according to EUCAST breakpoints [36] , as a result of a T86I mutation in the gene encoding the DNA gyrase A subunit [37] . They also became more resistant to ciprofloxacin between June 2011 and January 2013, coinciding with ciprofloxacin treatment in January and August 2012. These isolates contained an additional S460F amino acid change in the gene encoding the DNA gyrase B subunit. This mutation has not previously been reported in Campylobacter. An equivalent mutation (S464F) is associated with fluoroquinolone resistance in Pseudomonas aeruginosa [38] and Escherichia coli [39] .
The profiles of susceptibility to the other antimicrobial agents tested were similar for the 16 ST45 isolates (Supplementary Figure 8) . All isolates contained the A2058T mutation in the 23S rRNA gene associated with erythromycin resistance [40] . The isolates were also resistant to sulfamethoxazole and trimethoprim by an unknown mechanism (Supplementary Materials).
Motility
The first Campylobacter isolate collected from the patient (in 2006) was the most motile, whereas the second isolate (collected in 2008) was the least motile. Isolates collected from 2009 onward displayed less variation in motility, compared with the first 2 isolates (Figure 4 ). There was no difference in motility between isolates collected from the same occurrence of diarrhea (Supplementary Figure 7) .
DISCUSSION
Long-term Campylobacter excretion may arise from continued or recurring colonization. Recurrent colonization may result from exposure to multiple Campylobacter sources or continued exposure to a single source. The isolates collected from the patient were closely related, with a date of common ancestor coinciding with the date that the patient began to experience daily episodes of diarrhea. If the patient had been exposed to multiple Campylobacter sources, we would have expected the collected isolates to be more distantly related, with an earlier date of common ancestor. In addition, we were unable to identify any Campylobacter sources in the patient's domestic environment, and the Campylobacter population developed resistance to antibiotics during times that the patient was prescribed similar antibiotics. This suggests that the patient's longterm excretion of Campylobacter organisms was the result of continued colonization and demonstrates how genomic and epidemiological analyses can help shed light on a patient's infection history.
It is unknown how long-term Campylobacter excretion has affected the patient. Since diarrhea began, all fecal samples collected from the patient have been positive for Campylobacter organisms. This suggests a chronic infection. Investigations in previous studies on recurrent Campylobacter excretion were able to diagnose chronic campylobacteriosis on the basis of symptom alleviation following Campylobacter removal or antibiotic use [4, 5] . In the current study, the patient was continuously colonized with Campylobacter organisms and the onset of certain antibiotic therapies were associated with decreased diarrhea severity. However, decreased diarrhea severity was also associated with the onset of certain immunosuppressive therapies and changes in diet, and none of these therapies or diets stopped diarrhea or caused Campylobacter-negative feces. In addition, findings of endoscopies, gastroscopies, and gastrointestinal biopsies performed on the patient have at various times been consistent with a wide range of gastrointestinal disorders. Therefore, it is possible that the patient has an underlying gastrointestinal disorder that has allowed them to be colonized with Campylobacter organisms for this length of time, similarly to how chronic obstructive pulmonary disease (COPD) allows persistent P. aeruginosa lung colonization [41] . CVID is a primary immunosuppressive disease characterized by reduced serum immunoglobulin A and immunoglobulin G concentrations [42] . Patients with CVID have a higher risk of bacterial infections and noninfectious gastrointestinal diseases [33] . Campylobacter species have been isolated from patients with CVID with and without diarrhea [43] . Therefore, the patient's CVID has probably contributed to their long-term Campylobacter colonization, but they may contain an additional noninfectious gastrointestinal disease that may be the cause of their diarrhea. Anti-Campylobacter antibody assays may help determine whether the patient has mounted an immune response to Campylobacter organisms, and any association between anti-Campylobacter antibodies and diarrhea severity may suggest that Campylobacter organisms are the diarrheal cause.
Flagella allow Campylobacter to move through the viscous mucus layer and colonize the intestinal tract [44] . Therefore, motile Campylobacter species are often selected for on passage through human [45] and poultry [46] hosts. However, these studies investigated the immediate selection pressures on Campylobacter organisms. Studies of patients with COPD found that long-term P. aeruginosa colonization selected for nonmotile isolates [47] . The loss of motility enabled P. aeruginosa to evade phagocytes [48] . In this study, there was a large amount of variation in motility between the first 2 Campylobacter isolates obtained from the patient but less variation in the other 14 Campylobacter isolates. This may suggest that the Campylobacter isolates reached a trade-off between decreased motility to evade the immune response and the need for motility to colonize the gastrointestinal tract.
The patient's medical records revealed that they had been prescribed multiple courses of antibiotics from 2006 to 2016. Two of these courses coincided with an increased resistance to ampicillin and ciprofloxacin. This suggests that the patient's antibiotic therapies acted as evolutionary bottlenecks, removing all susceptible ST45 variants within the host as a result of selective sweeps [49] . This hypothesis is supported by the relatively small amount of genetic diversity between the 10 isolates collected from the same fecal sample relative to the amount of time the patient has been colonized. Similar findings were reported by Rodrigo-Troyano et al [50] , with P. aeruginosa isolates developing resistance to the antibiotics patients with COPD were prescribed. However, they also observed the coexistence of isolates with different antimicrobial susceptibilities within the same host. Further work is required to investigate within-host diversity and how it is influenced by antibiotic therapy and other factors.
In summary, we have described the evolution of C. jejuni ST45 within a persistently colonized human host. Our results suggest that the patient was colonized with ST45 between 1998 and 2006 and that ST45 evolved within the patient's gastrointestinal tract, developing resistance to antibiotics the patient was prescribed and undergoing selection for changes in motility.
Our results also demonstrate how genomic and phylogenetic analyses can give insight into a patient's infection history.
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